CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 53.40
-1.35 (-2.47%)
Sep 10, 2025, 1:45 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 17.81 billion as of September 9, 2025. Its market cap has increased by 130.22% in one year.
Market Cap
17.81B
Enterprise Value
16.29B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
53.40
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 17.81B, an increase of 135.20%. That is a compound annual growth rate of 14.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 17.80B | 53.34% |
| Dec 31, 2024 | 11.61B | -7.06% |
| Dec 29, 2023 | 12.49B | -54.89% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | 74.41B | 466.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.19B |
| Hansoh Pharmaceutical Group Company | 224.72B |
| JD Health International | 204.41B |
| Innovent Biologics | 176.58B |
| Sino Biopharmaceutical | 159.35B |
| WuXi Biologics | 150.75B |
| Akeso | 142.50B |
| CSPC Pharmaceutical Group | 127.94B |